TALKW
Talkspace, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.00
−94.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 238.4M | 228.9M | 187.6M | 150.0M | 119.6M |
| Cost of Revenue | 137.7M | 130.5M | 101.8M | 75.7M | 59.2M |
| Gross Profit | 100.7M | 98.3M | 85.8M | 74.4M | 60.3M |
| Operating Expenses | |||||
| R&D Expense | 11.7M | 9.5M | 10.5M | 17.6M | 21.7M |
| SG&A Expense | 83.0M | 75.6M | 73.3M | 73.9M | 109.1M |
| General & Admin Expense | 29.4M | 21.8M | 22.6M | 21.3M | 36.3M |
| Selling & Marketing Expense | 53.7M | 53.8M | 50.7M | 52.5M | 72.8M |
| Other Expenses | 8.8M | 10.1M | 6.5M | 6.2M | 6.6M |
| Total Operating Expenses | 103.6M | 95.2M | 90.3M | 97.6M | 137.4M |
| Cost and Expenses | 241.3M | 225.7M | 192.1M | 173.3M | 196.6M |
| Operating Income (EBIT) | (2.9M) | 3.2M | (4.5M) | (23.2M) | (77.0M) |
| Non-Operating | |||||
| Interest Income | 3.7M | 5.2M | 5.7M | 4.2M | 3.7M |
| Interest Expense | 945.0K | — | — | — | — |
| Net Interest Income | 2.7M | 5.2M | 5.7M | 4.2M | 3.7M |
| Other Non-Op Income/Expense | 4.6M | 5.2M | 5.7M | 4.2M | (2.4M) |
| Non-Operating Income (excl Interest) | (4.7M) | (5.2M) | (5.7M) | (4.2M) | 2.4M |
| EBT (Pre-Tax Income) | 1.7M | 8.4M | 1.2M | (19.0M) | (79.4M) |
| Income Tax Expense | 575.0K | 574.0K | 94.0K | 218.0K | 254.0K |
| Bottom Line | |||||
| Net Income | 1.2M | 7.8M | 1.1M | (19.2M) | (79.7M) |
| Earnings from Cont. Ops | 1.2M | 7.8M | 1.1M | (19.2M) | (79.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.2M | 7.8M | 1.1M | (19.2M) | (79.7M) |
| Per Share | |||||
| Basic EPS | $0.00 | $0.05 | $0.01 | ($0.12) | ($0.51) |
| Diluted EPS | $0.00 | $0.04 | $0.01 | ($0.12) | ($0.51) |
| Revenue Per Share | $1.42 | $1.36 | $1.11 | $0.91 | $0.76 |
| Shares | |||||
| Basic Shares Outstanding | 168.4M | 168.4M | 168.9M | 165.0M | 156.9M |
| Diluted Shares Outstanding | 173.8M | 173.8M | 176.5M | 165.0M | 156.9M |
| Profitability Metrics | |||||
| EBITDA | 6.2M | 11.2M | 2.1M | (17.8M) | (78.1M) |
| D&A | 4.4M | 2.9M | 859.0K | 1.2M | 1.4M |
| EBIT | 1.8M | 8.4M | 1.2M | (19.0M) | (79.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026